期刊
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS
卷 9, 期 1, 页码 258-261出版社
ELSEVIER
DOI: 10.1016/j.jvsv.2020.04.001
关键词
Lymphatic malformation; Sildenafil; Phosphodiesterase-5 inhibitor
Sildenafil has shown benefit in treating some patients with complicated or refractory lymphatic malformations, leading to significant improvement in clinical symptoms.
Lymphatic malformations (LMs) are rare congenital anomalies. LMs are often refractory to standard treatments, including surgical resection, debulking, and sclerotherapy. Use of sildenafil, a phosphodiesterase-5 inhibitor, for treatment of pediatric LMs has been reported with demonstrated benefit to some patients. This case series reports treatment of three patients (aged 14-37 years) suffering from complicated or refractory LMs with a low-dose oral phosphodiesterase-5 inhibitor, resulting in significant clinical improvement.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据